Summit Therapeutics plc Revenue and Competitors
Estimated Revenue & Valuation
- Summit Therapeutics plc's estimated annual revenue is currently $18.8M per year.
- Summit Therapeutics plc's estimated revenue per employee is $155,000
Employee Data
- Summit Therapeutics plc has 121 Employees.
- Summit Therapeutics plc grew their employee count by -15% last year.
Summit Therapeutics plc's People
| Name | Title | Email/Phone |
|---|---|---|
1 | General Counsel | Reveal Email/Phone |
2 | Head Information Technology | Reveal Email/Phone |
3 | Head Biometrics | Reveal Email/Phone |
4 | Head CMC & supply chain | Reveal Email/Phone |
5 | Head Regulatory Affairs | Reveal Email/Phone |
6 | Head Human Resources | Reveal Email/Phone |
7 | Head Corporate Marketing | Reveal Email/Phone |
8 | Head Clinical Pharmacology and DMPK | Reveal Email/Phone |
9 | Sr. Executive Director Regulatory | Reveal Email/Phone |
10 | Senior Director IT | Reveal Email/Phone |
Summit Therapeutics plc Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Summit Therapeutics plc?
Any statements in this press release about the Company’s future expectations, plans and prospects, including but not limited to, statements about the clinical and preclinical development of the Company’s product candidates, the therapeutic potential of the Company’s product candidates, the potential commercialisation of the Company’s product candidates, the sufficiency of the Company’s cash resources, the timing of initiation, completion and availability of data from clinical trials, the potential submission of applications for marketing approvals and other statements containing the words \"anticipate,\" \"believe,\" \"continue,\" \"could,\" \"estimate,\" \"expect,\" \"intend,\" \"may,\" \"plan,\" \"potential,\" \"predict,\" \"project,\" \"should,\" \"target,\" \"would,\" and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act
keywords:N/A
N/A
Total Funding
121
Number of Employees
$18.8M
Revenue (est)
-15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Summit Therapeutics plc News
... Pfizer Incorporated, SUMMIT Therapeutics Plc., Sarepta Therapeutics, PTC Therapeutics, Pharmacia & Upjohn LLC. Photo of Scott Edwards...
Fortress Biotech Announces Virtual Two-Day R&D Summit Hosted by B. Riley Securities on ... 2:00 p.m. ET - Panel #2 Cyprium Therapeutics.
With 6.2% and 2.7% of the shares outstanding respectively, Polar Capital Holdings plc and Mahkam Zanganeh are the second and third largest...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $25.4M | 121 | 5% | N/A |
#2 | $3.5M | 121 | 8% | N/A |
#3 | $32.7M | 121 | 41% | N/A |
#4 | $18.9M | 122 | 3% | $637M |
#5 | N/A | 122 | 21% | N/A |